173 related articles for article (PubMed ID: 35568099)
21. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
22. Endoplasmic reticulum stress promotes the release of exosomal PD-L1 from head and neck cancer cells and facilitates M2 macrophage polarization.
Yuan Y; Jiao P; Wang Z; Chen M; Du H; Xu L; Xu J; Dai Y; Wu FG; Zhang Y; Wu H
Cell Commun Signal; 2022 Jan; 20(1):12. PubMed ID: 35090495
[TBL] [Abstract][Full Text] [Related]
23. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
24. GAD1-mediated GABA elicits aggressive characteristics of human oral cancer cells.
Dou Z; Li M; Shen Z; Jiang H; Pang X; Li T; Liang X; Tang Y
Biochem Biophys Res Commun; 2023 Nov; 681():80-89. PubMed ID: 37774573
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
Li X; Ren H
Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
[TBL] [Abstract][Full Text] [Related]
26. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
27. CircLPAR3 Acts as an Oncogene in Oral Squamous Cell Carcinoma Through Regulating the miR-643/HMGB2 Network.
Fu Y; Qiu C; Yang Y; Lu J; Qi Y
Biochem Genet; 2022 Jun; 60(3):882-898. PubMed ID: 34528144
[TBL] [Abstract][Full Text] [Related]
28. HMGB1-activated tumor-associated macrophages promote migration and invasion via NF-κB/IL-6 signaling in oral squamous cell carcinoma.
Jiang M; Liu L; Huang W; Qi Y; Li Y; Li B
Int Immunopharmacol; 2024 Jan; 126():111200. PubMed ID: 37988913
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic circDHTKD1 promotes tumor growth and metastasis of oral squamous cell carcinoma in vitro and in vivo via upregulating miR-326-mediated GAB1.
Wu Z; He X; Chen S
Braz J Med Biol Res; 2021; 54(10):e10837. PubMed ID: 34287578
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
31. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
32. FERMT2 upregulation in CAFs enhances EMT of OSCC and M2 macrophage polarization.
Ma X; Zhao D; Liu S; Zuo J; Wang W; Wang F; Li Y; Ding Z; Wang J; Wang X
Oral Dis; 2024 Apr; 30(3):991-1003. PubMed ID: 37357349
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
Chen H; Sa G; Li L; He S; Wu T
Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
[TBL] [Abstract][Full Text] [Related]
35. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
[TBL] [Abstract][Full Text] [Related]
36. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion.
Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C
Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916
[TBL] [Abstract][Full Text] [Related]
37. CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma.
Zhou WH; Wang Y; Yan C; Du WD; Al-Aroomi MA; Zheng L; Lin SF; Gao JX; Jiang S; Wang ZX; Sun CF; Liu FY
Discov Oncol; 2022 Jul; 13(1):67. PubMed ID: 35904690
[TBL] [Abstract][Full Text] [Related]
38. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
39. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
40. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.
Min L; Wang H; Qi H
Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
